These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32921623)

  • 1. [Clinical research in rare diseases: new challenges, opportunities and ethical issues].
    Alfonso Farnós I; Alcalde Bezhold G
    An Pediatr (Engl Ed); 2020 Oct; 93(4):219-221. PubMed ID: 32921623
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities.
    Krishnan ML; Berry-Kravis E; Capal JK; Carpenter R; Gringras P; Hipp JF; Miller MT; Mingorance A; Philpot BD; Pletcher MT; Rotenberg A; Tjeertes J; Wang PP; Willgoss T; de Wit MC; Jeste SS
    Nat Rev Drug Discov; 2021 Sep; 20(9):653-654. PubMed ID: 34002058
    [No Abstract]   [Full Text] [Related]  

  • 3. [The stakes of pre- and post-market authorization development and clinical assessment].
    Schwebig A
    Presse Med; 2012 May; 41 Suppl 1():S6-8. PubMed ID: 22483770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ethical aspects of clinical trials in rare diseases].
    Hasford J; Koch A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):556-562. PubMed ID: 28275835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial design for rare cancers: why a less conventional route may be required.
    Panageas KS
    Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.
    Dawkins HJS; Draghia-Akli R; Lasko P; Lau LPL; Jonker AH; Cutillo CM; Rath A; Boycott KM; Baynam G; Lochmüller H; Kaufmann P; Le Cam Y; Hivert V; Austin CP;
    Clin Transl Sci; 2018 Jan; 11(1):11-20. PubMed ID: 28796411
    [No Abstract]   [Full Text] [Related]  

  • 8. A unifying strategy for clinical trials in rare urological malignancy.
    Nicholson S
    Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of research collaborations and consortia in rare cancers.
    Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
    Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of developing and conducting clinical trials in rare disorders.
    Kempf L; Goldsmith JC; Temple R
    Am J Med Genet A; 2018 Apr; 176(4):773-783. PubMed ID: 28815894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focusing on rare diseases in China: are we there yet?
    Yang L; Su C; Lee AM; Bai HX
    Orphanet J Rare Dis; 2015 Nov; 10():142. PubMed ID: 26525984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodology of clinical trials for rare diseases.
    Tudur Smith C; Williamson PR; Beresford MW
    Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):247-62. PubMed ID: 24974061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Rare Diseases.
    Bax BE
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Aymé S; Bockenhauer D; Day S; Devuyst O; Guay-Woodford LM; Ingelfinger JR; Klein JB; Knoers NVAM; Perrone RD; Roberts J; Schaefer F; Torres VE; Cheung M; Wheeler DC; Winkelmayer WC;
    Kidney Int; 2017 Oct; 92(4):796-808. PubMed ID: 28938953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Presenting a research project on rare diseases to industrial companies].
    Ferry A
    Presse Med; 2012 May; 41 Suppl 1():S38-9. PubMed ID: 22483767
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare-disease project has global ambitions.
    Abbott A
    Nature; 2011 Apr; 472(7341):17. PubMed ID: 21475168
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic challenges and new therapies for rare lysosomal storage diseases.
    Hesselgrave B
    Case Manager; 2003; 14(6):48-52. PubMed ID: 14618149
    [No Abstract]   [Full Text] [Related]  

  • 18. Valuable lessons from analyses of common signs and symptoms in rare diseases.
    Matsumoto K
    Allergol Int; 2021 Oct; 70(4):405-406. PubMed ID: 34493448
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.
    Behera M; Kumar A; Soares HP; Sokol L; Djulbegovic B
    Cancer Control; 2007 Apr; 14(2):160-6. PubMed ID: 17387301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some ethical implications of "adaptive" trials.
    Petrini C
    Clin Ter; 2015; 166(4):149-50. PubMed ID: 26378749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.